Spearhead Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Spearhead Capital Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$244K	Sell
2022 Q1	$258K	Sell
2021 Q4	$467K	Buy
2021 Q3	$475K	Sell
2021 Q2	$401K	Buy
2021 Q1	$321K	Buy
2020 Q4	$331K	Buy
2020 Q3	$263K	Buy
2020 Q2	$282K	Buy